Sign inJoin waitlistJoin the waitlist

Cecilia Larocca

Instructor in Dermatology, Harvard Medical School · Mass General Brigham

Credentials: · · · · ·

History

Mass General Brigham
Present

Dermatology
Boston Medical Center
2013–2016
Internal Medicine
Mount Sinai Morningside
2012–2013
Johns Hopkins Univ Sch of Med
2008–2012

Research

Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor
Chemistry & Biology · 2010 · 533 citations
Viral vector-based therapeutic cancer vaccines
Review · The Cancer Journal · 2011 · First of 2 authors · 165 citations
Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells
Journal of Investigative Dermatology · 2013 · 92 citations

NL
Nicole LeBoeuf
23 papers
Thomas Kupper
10 papers
Michi Shinohara
9 papers · 4 as a fellow
David Fisher
6 papers
CV
Cesar Virgen
5 papers · 4 as a resident
Joseph Merola
5 papers
AB
Ai-Tram Bui
4 papers · 2 as a resident
Alice Gottlieb
4 papers
April Armstrong
4 papers
Daniel Siegel
4 papers
Jesse Hirner
4 papers · 2 as a resident
Nanette Silverberg
4 papers

Grants

Evaluation of an Implantable Microdevice for Rapid Cancer Drug Screening Directly in T Cell Lymphoma Patients
National Cancer Institute · R37
Contact PI · $4M · Brigham and Women's Hospital
2020–2027

Clinical trials

A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma
Principal investigator · Recruiting
Dana-Farber Cancer Institute
2019–2028
A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab
Site PI · Recruiting
City of Hope Medical Center
2024–2026